HRLMP - Service - Newsletters - Spring, 1995 Issue No. 39, QUARTERLY NEWSLETTER, Spring, 1995. activated protein c resistance AND THROMBOSIS. What tests are used to detect activated protein c resistance? http://www.fhs.mcmaster.ca/hrlmp/service/news3995.htm
Extractions: http://www.fhs.mcmaster.ca/hrlmp/ Issue No. 39 QUARTERLY NEWSLETTER Spring, 1995 ACTIVATED PROTEIN C RESISTANCE AND THROMBOSIS In the last two years, a new coagulation disorder, termed "activated protein C resistance" or "APC resistance" has been identified as an important cause of inherited thrombotic disease. Most individuals with APC resistance have been shown to have a mutation in the factor V gene that causes the coagulation factor V protein to escape regulation by the protein C anticoagulant pathway. This results in a disturbance in the normal balance between hemostasis and clot promotion. Because the mutation associated with this abnormality occurs in many parts of the world, APC resistance has become recognized as one of the most frequent causes of inherited, prothrombotic disease. In health, clot formation is balanced by a natural anticoagulant system, the protein C pathway. The coagulation factors Va and VIIIa are key non-enzymatic components of the hemostatic pathway. Together, they accelerate coagulation 300,000 fold by promoting the assembly of procoagulant enzyme complexes. When coagulation occurs, protein C is activated, and, together with protein S, it inactivates factors Va and VIIIa by proteolytic cleavage. Although defects in the protein C anticoagulant pathway, due to deficiencies in protein C or protein S, have been recognized for many years; these disorders occur infrequently in patients with inherited thrombotic disease. Similarly, defects in antithrombin, another important natural anticoagulant, are also rare. Together, protein C, protein S and antithrombin deficiencies are found in only 10-15% of patients with thrombophilia or inherited thrombotic disease.
PROGEN GMBH --- Diagnostics --- Research Products --- Point-of-Care --- Translate this page activated protein c resistance Control Kit. Kontrollsatz für das activated protein c resistance Sensitivity Kit, enthält je 5 x http://www.progen.de/index_D.php?a=diagnostik_home&b=einzelprodukt&c=876
PROGEN GMBH --- Diagnostics --- Research Products --- Point-of-Care --- Translate this page activated protein c resistance Sensitivity Kit. Reagenziensatz zum funktionellen Nachweis der hereditären und erworbenen Resistenz http://www.progen.de/index_D.php?a=diagnostik_home&b=einzelprodukt&c=879
:: Ez2Find :: Factor V Leiden activated protein c resistance Site Info - Translate - Open New Window Discusses the thrombotic risks of this inherited disorder, also known as Factor http://ez2find.com/cgi-bin/directory/meta/search.pl/Health/Conditions_and_Diseas
Extractions: Any Language English Afrikaans Arabic Bahasa Melayu Belarusian Bulgarian Catala Chinese Simplified Chinese Traditional Cymraeg Czech Dansk Deutsch Eesti Espanol Euskara Faroese Francais Frysk Galego Greek Hebrew Hrvatski Indonesia Islenska Italiano Japanese Korean Latvian Lietuviu Lingua Latina Magyar Netherlands Norsk Polska Portugues Romana Russian Shqip Slovensko Slovensky Srpski Suomi Svenska Thai Turkce Ukrainian Vietnamese Mode Guides Factor V Leiden Web Sites Activated Protein C Resistance [Site Info] [Translate] [Open New Window] Factor Five Leiden Support [Site Info] [Translate] [Open New Window] Support for sufferers of the Factor Five Leiden blood clotting disorder, an inherited blood condition discovered in 1995. History, glossary, and meeting information (Oregon).
AKU-AKUH Clinical Laboratories HOSPITAL SERVICES. Clinical Laboratories. LABRAD. activated protein c resistance A COMMON RISK FACTOR FOR THROMBOSIS Muhammad Salman. http://www.aku.edu/akuh/hs/cl/labrad-23-th9.shtml
Extractions: The penetration of clinical manifestations among APCR individuals is variable, and a majority of heterozygous carriers of FV:Q506 actually never experience any symptoms. In fact, not even homozygous carriers will necessarily be affected by thrombosis during their life time. FV:Q506 is a mild risk factor per se and that the probability of APCR individual developing thrombosis is dependent on the co-existence of other risk factors. About 60% of APCR patients have their first thrombotic event in combination with pregnancy, oral contraceptives, trauma or surgery. The clinical manifestations of inherited, heterozygous protein defects in familial thrombophilia involving antithrombin, protein C, protein S and factor V are fairly similar, Mutations affecting the qualitative or quantitative function of these proteins often results in venous thromboembolism at a young age (before the age of 45 years) and are followed by a tendency towards recurrent thrombotic episodes.
Griffin Laboratory - Publications activated protein c resistance caused by Arg506Gln mutation in factor Va. Lancet 34313611362, 1994. 5. Greengard JS, Eichinger S, Griffin JH, Bauer KA. http://www.scripps.edu/mem/eht/griffin/publications.html
Extractions: Laboratory Home Research Publications Personnel Selected publications (from 233 total) Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370-1373, 1981. Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate. Lancet November 19, 1165-1168, 1983. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 64:1297-1300, 1984. Greengard JS, Sun X, Xu X, Fernandez JA, Evatt B, Griffin JH. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343:1361-1362, 1994. Greengard JS, Eichinger S, Griffin JH, Bauer KA. Variability of thrombosis among homozygous siblings resistant to activated protein C due to Arg506Gln-Factor V. N Engl J Med 331:1559-1562, 1994. Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Activated protein C resistance: Molecular mechanisms based on studies using purified Gln506-factor V.
Extractions: Related links of interest: Health:Conditions and Diseases:Genetic Disorders Health:Conditions and Diseases:Cardiovascular Disorders:Vascular Disorders:Thrombosis Activated Protein C Resistance - Discusses the thrombotic risks of this inherited disorder, also known as Factor V Leiden. Factor Five Leiden Support - Support for sufferers of the Factor Five Leiden blood clotting disorder, an inherited blood condition discovered in 1995. History, glossary, and meeting information (Oregon). Living with Factor V Leiden - Factor V Leiden is the most common hereditary blood coagulation disorder in the United States. It is present in 5% of the American population. The Role of Activated Protein C Resistance in the Pathogenesis of Venous Thrombosis - Center for Disease Control's page discussing the background of this disorder including study results, testing, and complications. University of Illinois Patient Resources - Description of factor V Leiden, its risks and treatment options. Also discusses the impact of other conditions on this disease. Yahoo! Groups: Leiden Factor V Support
Scripta Academica Lundensis Dissertations From mutation; APC resistance Abstract activated protein c resistance (APC resistance) is the most common hereditary condition associated with venous thrombosis. http://www.lub.lu.se/cgi-bin/show_diss.pl?db=global&fname=med_167.html
MP Forum - Medyczna Lista Dyskusyjna Serwisu MP OnLine RE MPForum activated protein c resistance. To mp-forum@medprakt.pl ; Subject RE MP-Forum activated protein c resistance; http://www.mp.pl/mp-forum/archiwum/index.php?dir=200202&wysw=msg00002.html
MP Forum - Medyczna Lista Dyskusyjna Serwisu MP OnLine MPForum activated protein c resistance. Subject MP-Forum activated protein c resistance; Nastepny wg watku RE MP-Forum activated protein c resistance; http://www.mp.pl/mp-forum/archiwum/index.php?dir=200202&wysw=msg00001.html
Coagulation And Transfusion Medicine Coagulation and Transfusion Medicine / Original Article. activated protein c resistance Assay Detects Thrombotic Risk Factors Other Than Factor V Leiden. http://www.ajcp.com/previews/abstracts/202180artoc.html
Extractions: Laurie L. Graf, CLSp(MB), Carolyn H. Welsh, MD, Zainab Qamar, and Richard A. Marlar, PhD Key Words: Activated protein C resistance; Case-control study; Factor V Leiden; Factor VIII; HR2 haplotype; Venous thromboembolism DOI: 10.1092/LX9E6Y043P58YVCL Abstract Activated protein C (APC) resistance is a common risk factor for venous thromboembolism (VTE) attributed to various mechanisms, including factor V Leiden (FVL) polymorphism. FVL is considered responsible for up to 95% of APC resistance; however other factor V polymorphisms and elevated factor VIII levels also have been implicated. We value your input... If you have something to say regarding this article or ajcp.com in general, share it with us. If you would like to give us feedback on the Web site in general or make corrections to this article, click on Feedback below. To write correspondence to the editor regarding this article, please click on Comment below. Thank you. more abstracts Order full text article Comment
AMS Reference Lab: Search Results Search Again . activated protein c resistance. Test Number 7500485. Component(s) APCR2/APCR1 RATIO, ACT PROT C RESIST INTERP, ACTIVATED PROTEIN C RES. 1, 85307. http://www.amsreferencelab.com/cgi-bin/test-directory?page=details&item=7500485-
Extractions: @import url(http://www.nlm.nih.gov/medlineplus/images/advanced.css); Skip navigation Other encyclopedia topics: A-Ag Ah-Ap Aq-Az B-Bk ... Z Contents of this page: Blood clot formation Blood clots Definition Return to top These inherited disorders of blood coagulation are caused by deficiency of the Vitamin K-dependent plasma proteins C or S that are naturally occurring anticoagulants. The disorder results in an increased tendency for intravascular blood clot formation. Causes, incidence, and risk factors Return to top Congenital protein C or S deficiency is an inherited disorder that causes abnormal blood clotting. Normal blood coagulation is a complex process involving as many as 20 different plasma proteins which are known as blood coagulation factors. A series of complex chemical reactions using these factors takes place very rapidly to form an insoluble protein called fibrin that stops bleeding . Other plasma proteins, such as proteins C and S, inhibit or reverse the cascade to prevent excessive clotting.
Www.nlm.nih.gov/cgi/mesh/2K/MB_cgi?term=Activated+Protein+C+Resistance American Journal of Critical Care Role of activated protein C in alfa (activated), a recombinant form of human activated protein C, in patients increases in nosocomial infections and antimicrobial resistance to antibiotic http://www.nlm.nih.gov/cgi/mesh/2K/MB_cgi?term=Activated Protein C Resistance
FACTOR V LEIDEN SCREEN molecular weight heparin therapy. Methods activated protein c resistance, functional clotting test. Clinical Utilities Screening test http://www.mgh.org/lab/CATALOG/TESTS/5434.HTM
ALCOHOL, URINE activated protein c resistance. Synonyms Factor V Leiden Screen. Lab Test Code APCRE. Test Performed In Hematology. Test Methodology Clotting Assay. http://www.ucihs.uci.edu/com/pathology/PathologyServicesManual/..\Pathology Serv
Extractions: ACTIVATED PROTEIN C RESISTANCE Synonyms: Factor V Leiden - Screen Lab Test Code: APCRE Test Performed In: Hematology Test Methodology: Clotting Assay Availability: Varies (once per week) Patient Preparation: Specimen Requirements: Draw blood in light blue-top (3.2% or 3.8% sodium citrate) tube(s). Immediately centrifuge at 1,500 G for 10 minutes to remove platelets, and send 2.0 mL of citrate platelet-poor plasma frozen in a plastic vial on dry ice. THE CORRECT RATIO OF BLOOD TO ANTICOAGULANT (9:1) IS CRITICAL. If the tubes are under filled, specimen must be recollected as results will not be accurate. A CLEAN VENIPUNCTURE IS ESSENTIAL TO AVOID SPECIMEN ACTIVATION. Reference Values: Additional Information: CPT Code(s):
JW (General) -- Sign In activated protein c resistance Is a Risk Factor for VTE. Comment It appears that resistance to activated protein C is an independent risk factor for VTE. http://general-medicine.jwatch.org/cgi/content/full/1999/511/8
Extractions: All customers have full-text access to the Journal Watch publication(s) to which they have a subscription. Other registered users have access to Journal Watch Online content older than six months and may request e-mail notification of current contents. Subscribers and Registered Users User Name Password If you are a subscriber using Journal Watch Online for the first time you must activate and choose a password Remember my user name and password. Forgotten your password? If you do not use cookies sign in here (After you click the 'Sign In' button you may have to wait for several seconds. Thank you for your patience.)
Faculty At The Department Of Pediatrics Sensitivity, Specificity and Predictive Value of Modified Assays for activated protein c resistance in Children Thrombosis and Hemostasis 79(3) 567-70 http://www.siumed.edu/peds/brandt.htm
